ATE399860T1 - Mutation innerhalb des connexin 26 gens und bezug zu prelingualer syndromloser taubheit sowie detektionsverfahren - Google Patents

Mutation innerhalb des connexin 26 gens und bezug zu prelingualer syndromloser taubheit sowie detektionsverfahren

Info

Publication number
ATE399860T1
ATE399860T1 AT98945246T AT98945246T ATE399860T1 AT E399860 T1 ATE399860 T1 AT E399860T1 AT 98945246 T AT98945246 T AT 98945246T AT 98945246 T AT98945246 T AT 98945246T AT E399860 T1 ATE399860 T1 AT E399860T1
Authority
AT
Austria
Prior art keywords
prelingual
mutation
syndromeless
connexin
deafness
Prior art date
Application number
AT98945246T
Other languages
English (en)
Inventor
Christine Petit
Francoise Denoyelle-Gryson
Dominique Weil
Sandrine Marlin-Duvernois
Jean-Luc Guesdon
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE399860T1 publication Critical patent/ATE399860T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98945246T 1997-08-15 1998-08-14 Mutation innerhalb des connexin 26 gens und bezug zu prelingualer syndromloser taubheit sowie detektionsverfahren ATE399860T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5586397P 1997-08-15 1997-08-15

Publications (1)

Publication Number Publication Date
ATE399860T1 true ATE399860T1 (de) 2008-07-15

Family

ID=22000653

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98945246T ATE399860T1 (de) 1997-08-15 1998-08-14 Mutation innerhalb des connexin 26 gens und bezug zu prelingualer syndromloser taubheit sowie detektionsverfahren

Country Status (11)

Country Link
US (7) US6485908B1 (de)
EP (1) EP1003865B1 (de)
JP (1) JP4418587B2 (de)
AT (1) ATE399860T1 (de)
CA (3) CA2720384C (de)
CY (1) CY1108771T1 (de)
DE (1) DE69839671D1 (de)
DK (1) DK1003865T3 (de)
ES (1) ES2308813T3 (de)
PT (1) PT1003865E (de)
WO (1) WO1999009210A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2720384C (en) 1997-08-15 2014-08-12 Institut Pasteur Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection
US6013449A (en) * 1997-11-26 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Probe-based analysis of heterozygous mutations using two-color labelling
EP1320745A4 (de) * 2000-09-01 2008-10-01 Applera Corp System und verfahren zur temperaturgradienten-kapillarelektrophorese
CA2425413A1 (en) * 2000-10-11 2002-04-18 Spectrumedix Corporation System and method for determining the presence of methylated cytosines in polynucleotides
AU2002326957B2 (en) 2001-09-19 2006-08-10 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Transductin-1 and transductin-2 and applications to hereditary deafness
EP1451372A1 (de) * 2001-10-18 2004-09-01 Spectrumedix Corporation System und verfahren zur kapillarelektrophorese mit temperaturgradienten
NL1019226C2 (nl) * 2001-10-25 2003-04-28 Multigen Holding S A Werkwijze voor het detecteren van een mutatie die verband houdt met plaveiselcelcarcinoom.
EP1308458A1 (de) * 2001-10-30 2003-05-07 GenOdyssee Neue Polynukleotide und Polypeptide des CX26 Gens
US6872530B2 (en) * 2002-04-24 2005-03-29 Spectrumedix, Llc Method for determining the presence of DNA variants using peptide nucleic acid probes
AU2003253922A1 (en) * 2002-07-15 2004-02-02 Spectrumedix Llc System and method for determining known dna variants with temperature gradient electrophoresis
WO2004007690A2 (en) * 2002-07-16 2004-01-22 Spectrumedix Llc Method and system for comparative genomics for organisms using temperature gradient electrophoresis
AU2002952702A0 (en) * 2002-11-18 2002-11-28 Murdoch Childrens Research Institute A diagnostic assay
US7700750B2 (en) * 2003-01-09 2010-04-20 Third Wave Technologies, Inc. Connexin allele detection assays
US20040166495A1 (en) * 2003-02-24 2004-08-26 Greinwald John H. Microarray-based diagnosis of pediatric hearing impairment-construction of a deafness gene chip
US7303879B2 (en) * 2003-07-31 2007-12-04 Applera Corporation Determination of SNP allelic frequencies using temperature gradient electrophoresis
US7166433B2 (en) * 2004-03-03 2007-01-23 The United States Of America As Represented By The Department Of Health And Human Services Transductin-1 and transductin-2 and applications to hereditary deafness
US7276804B2 (en) * 2005-06-22 2007-10-02 C.E. Niehoff & Co. Voltage regulator with improved protection and warning system
US20070134691A1 (en) * 2005-11-21 2007-06-14 Iris Schrijver Methods and compositions for determining whether a subject carries a gene mutation associated with hereditary hearing loss
EP3973079A1 (de) * 2019-05-22 2022-03-30 Regeneron Pharmaceuticals, Inc. Varianten von synaptojanin 2 (synj2) und verwendungen davon

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228805A (en) 1978-11-08 1980-10-21 Rca Corporation Method of measuring blood perfusion
US4709703A (en) 1985-11-12 1987-12-01 Mayo Foundation Imaging system and method using radiopaque microspheres for evaluation of organ tissue perfusion
US5480382A (en) 1989-01-09 1996-01-02 Pilot Cardiovascular Systems, Inc. Steerable medical device
US5552541A (en) * 1990-06-20 1996-09-03 Beckman Instruments, Inc. Haptenic probes for detecting capture polynucleotides
US5190050A (en) 1991-11-08 1993-03-02 Electro-Catheter Corporation Tip deflectable steerable catheter
US5312415A (en) 1992-09-22 1994-05-17 Target Therapeutics, Inc. Assembly for placement of embolic coils using frictional placement
US6165139A (en) 1993-03-01 2000-12-26 Fonar Corporation Remotely steerable guide wire with external control wires
US5769796A (en) 1993-05-11 1998-06-23 Target Therapeutics, Inc. Super-elastic composite guidewire
US5358479A (en) 1993-12-06 1994-10-25 Electro-Catheter Corporation Multiform twistable tip deflectable catheter
US5661122A (en) 1994-04-15 1997-08-26 Genentech, Inc. Treatment of congestive heart failure
US5814062A (en) 1994-12-22 1998-09-29 Target Therapeutics, Inc. Implant delivery assembly with expandable coupling/decoupling mechanism
EP0725136A1 (de) * 1995-02-03 1996-08-07 Institut Pasteur Nukleotid- und Peptidsequenzen des USHER-1B Gens, diagnostische und therapeutische Anwendungen davon
US5855577A (en) 1996-09-17 1999-01-05 Eclipse Surgical Technologies, Inc. Bow shaped catheter
US6106473A (en) 1996-11-06 2000-08-22 Sts Biopolymers, Inc. Echogenic coatings
US5967991A (en) 1996-12-03 1999-10-19 Echocath, Inc. Drive apparatus for an interventional medical device used in an ultrasonic imaging system
US5876373A (en) 1997-04-04 1999-03-02 Eclipse Surgical Technologies, Inc. Steerable catheter
CA2720384C (en) 1997-08-15 2014-08-12 Institut Pasteur Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection
US5984929A (en) 1997-08-29 1999-11-16 Target Therapeutics, Inc. Fast detaching electronically isolated implant
US6179809B1 (en) 1997-09-24 2001-01-30 Eclipse Surgical Technologies, Inc. Drug delivery catheter with tip alignment
US6053899A (en) 1997-10-02 2000-04-25 Scimed Life Systems, Inc. Material delivery device and method of using the same
US6053870A (en) 1997-11-08 2000-04-25 Angiodynamics, Inc. Ultrasonic visible surgical needle
US6248112B1 (en) 1998-09-30 2001-06-19 C. R. Bard, Inc. Implant delivery system
US6146339A (en) 1999-05-24 2000-11-14 Advanced Cardiovascular Systems Guide wire with operator controllable tip stiffness
US6277082B1 (en) 1999-07-22 2001-08-21 C. R. Bard, Inc. Ischemia detection system

Also Published As

Publication number Publication date
JP4418587B2 (ja) 2010-02-17
CA2301301C (en) 2010-12-07
JP2001514904A (ja) 2001-09-18
EP1003865A2 (de) 2000-05-31
CA2852463A1 (en) 1999-02-25
US7258975B2 (en) 2007-08-21
US8143000B2 (en) 2012-03-27
CA2301301A1 (en) 1999-02-25
ES2308813T3 (es) 2008-12-01
US20160076101A1 (en) 2016-03-17
WO1999009210A3 (en) 1999-04-15
US6485908B1 (en) 2002-11-26
US8455195B2 (en) 2013-06-04
US20120322059A1 (en) 2012-12-20
US20090104600A1 (en) 2009-04-23
CA2852463C (en) 2017-08-29
US20030170676A1 (en) 2003-09-11
EP1003865B1 (de) 2008-07-02
CA2720384A1 (en) 1999-02-25
DK1003865T3 (da) 2008-11-10
DE69839671D1 (de) 2008-08-14
CA2720384C (en) 2014-08-12
US20140113285A1 (en) 2014-04-24
PT1003865E (pt) 2008-10-14
WO1999009210A2 (en) 1999-02-25
CY1108771T1 (el) 2014-04-09
US9169517B2 (en) 2015-10-27
US9868989B2 (en) 2018-01-16
US5998147A (en) 1999-12-07

Similar Documents

Publication Publication Date Title
CY1108771T1 (el) Μεταλλαξη εντος του γονιδιου κοννεξινης 26 υπευθυνου για προγλωσσικη μη-συνδρομικη κωφωση και μεθοδος ανιχνευσης
ATE247718T1 (de) Erkennung einer genetischen prädisposition fur osteoporose
FI951612A0 (fi) Menetelmiä synteettisten oligonukleotidien sekvensoimiseksi, jotka sisältävät nukleotidien välisiä ei-fosfodiesterisidoksia
DE69013516T2 (de) Calciumhypochloridzusammensetzungen zum verhindern von kesselsteinbildung und methode zu deren verwendung.
HUP9900623A2 (hu) Növényi protoporfirinogén oxidáz génekből származó promoterek
ATE412002T1 (de) Gruppen zum einfangen von nukleinsäuren
DE60028826D1 (de) Katalysatorzusammensetzung und verfahren für olefinpolymerisation
DE69426033D1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
DE69629489D1 (de) Fructosylaminosäuren oxidase, verfahren zu ihrer herstellung und zum testen von amadori-verbindungen unter zuhilfenahme des enzyms
DE69523586D1 (de) Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen
DE69330463D1 (de) Isolierte nukleotid-sequenzen zum nachweis von neisseria gonorrhoeae
DE69615285T2 (de) System zum Raffinieren von Gasen
DE59008975D1 (de) Verfahren zum überwachen von anlagen, wie autokrane, grossbagger oder dergleichen, und system zur verwirklichung dieses verfahrens.
DE69805284D1 (de) Diamantierter sägedraht zum scheiden von steinartigen materialien und verfahren zu seiner herstellung
DE69635446D1 (de) Pflanzenpromoter und dessen verwendung zur genexpression
DE69308584T2 (de) Neues kulturmilieu zum nachweiss e. coli und verfahren zu ihrer verwendung
ATE332974T1 (de) Il-1/tnf-alpha-activated kinase (itak), und verfahren zu ihrer herstellung und verwendung
DE69633671D1 (de) Verfahren zum nachweis von lebensfähigen cryptosporidium parvum oozysten
DE68914865T3 (de) Erneuerungsmethode für Kammerringofen.
ES2156860T3 (es) Tirosina quinasa.
ATE301189T1 (de) Neues verfahren zum nachweis von cryptosporidium
NO943008D0 (no) Renseblanding for gallegangen, samt fremgangsmåte for rensing av gallegangen
DE58902746D1 (de) Hydrophile copolymere, verfahren zu ihrer herstellung und ihre verwendung.
MD1261F1 (en) Method for evaluation of the triticale genotypes resistance to fusariose
ATE287440T1 (de) Zusammensetzungen zum entfernen von kalkstein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1003865

Country of ref document: EP